A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis
Clinical trial NCT03431610 · COMPLETED
Trial details
- NCT number
- NCT03431610
- Sponsor
- Novan, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2018-05-11
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.